1-20 of 598
liposomes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Descriptive Study on Healthcare Utilization and Costs in Secondary Acute Myeloid Leukemia Patients Treated with CPX-351 Versus Those Treated with 7+3

Free
Kwanza Price, MPH, Zhun Cao, PhD, Craig Lipkin, Scott Robinson, Deborah Ann Profant, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2213.
https://doi.org/10.1182/blood-2019-127075
Published: 2019
Journal Articles

Understanding the Mechanisms Underlying Thrombocytopenia in Visceral Leishmaniasis

Free
Gulab Fatima Rani, MBBS, Olivier Preham, PhD, Ian Hitchcock, PhD, Paul Kaye, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2378.
https://doi.org/10.1182/blood-2019-128133
Published: 2019
Journal Articles

The Role of Interferon, Inflammation and Infection in Aplastic Anemia

Free
Katherine C. MacNamara, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): SCI-34.
https://doi.org/10.1182/blood-2019-121036
Published: 2019
Journal Articles

Synthetic Platelets for Treatment of Traumatic Hemorrhage and Thrombocytopenia

Free
Anirban Sen Gupta, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): SCI-37.
https://doi.org/10.1182/blood-2019-121079
Published: 2019
Journal Articles

Molecular MRD Monitoring Is Feasible in the Majority of Children with AML and Is Highly Predictive of Outcome: Results from the International MyeChild01 Study

Free
Jelena Jovanovic, PhD, Nicola Potter, PhD, Anju Kanda, MSc, Claire Schwab, PhD, Aimee E Jackson, MSc, Richard Dillon, MA, PhD MRCP, FRCPath, Anna Lawson, BSc, Manohursingh Runglall, MSc, Paresh Vyas, MD PhD, Paul Virgo, Geoff Shenton, Nicholas Heaney, Beki James, MD, Katharine Patrick, MD, Persis J Amrolia, FRCP, FRCPath, PhD, Jean-Hugues Dalle, MD PhD, Gerard Michel, MD, Andrew S. Moore, MBBS,FRACP,PhD, Hélène Lapillonne, MD PhD, Claude Preudhomme, PharmD, PhD, Guy Leverger, MD, Owen P Smith, MD, Andre Baruchel, MD, Yves Bertrand, MD, Arnaud Petit, MD PhD, Keith Wheatley, DPhil, Pamela R. Kearns, PhDFRCPC, Christine J. Harrison, PhD FRCPath, Brenda Gibson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1393.
https://doi.org/10.1182/blood-2019-125257
Published: 2019
Journal Articles

Preliminary Results from CPX-351 Italian Compassionate Use Program Show High Response Rate and Good Tolerability in Poor Prognosis AML Patients

Free
Fabio Guolo, MD, Paola Minetto, MD, Luana Fianchi, MD, Michela Rondoni, MD, Giulia Daghia, MD, Stefano D'Ardia, MD, Monica Morselli, MD, Crescenza Pasciolla, MD, Francesca Pavesi, MD, Barbara MD Scappini, Francesco Lanza, MD, Marco Gobbi, MD, Livio Pagano, MD, Felicetto Ferrara, MD, Roberto Massimo Lemoli, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1363.
https://doi.org/10.1182/blood-2019-131329
Published: 2019
Journal Articles

In Vivo Efficacy of Anti-CD20-Interferon-Gamma Fusion Protein Against Syngeneic B Cell Lymphoma Is Mediated By Natural Killer Cells

Free
Alex Vasuthasawat, BS, MS, Reiko E Yamada, Kham R Trinh, Neiki Rokni, Sherie L Morrison, PhD, John M. Timmerman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1575.
https://doi.org/10.1182/blood-2019-131890
Published: 2019
Journal Articles

The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy

Free
Kathrine T. Isaksen, MD, Klaus Beiske, MD PhD, Erlend B. Smeland, MD PhD, Judit Jørgensen, MD PhD, Marianne Brodtkorb, MD PhD, June Helen Myklebust, PhD, Mats Jerkeman, MD Professor, Leo Meriranta, MD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Sirpa Leppa, MD PhD, David W. Scott, MBChB, PhD, Harald Holte, MD PhD, Yngvild Nuvin Blaker, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1485.
https://doi.org/10.1182/blood-2019-121467
Published: 2019
Journal Articles

ROR1 Targeted Immunoliposomal Delivery of OSU-2S Show Selective Cytotoxicity in t(1;19) Translocated B-ALL

Free
Swagata Goswami, MSc, Chi-Ling Chiang, PhD, Kevan Zapolnik, BS, Zhiliang Xie, James L. Lee, PhD, Sivasubramanian Baskar, Christoph Rader, PhD, John C. Byrd, MD, Mitch A. Phelps, PhD, Bhavana Bhatnagar, DO, Natarajan Muthusamy, DVM,PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3798.
https://doi.org/10.1182/blood-2019-128828
Published: 2019
Journal Articles

V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute Leukemia

Free
Laura Agresta, MD, Maureen M O'Brien, MD, Kana Mizuno, PhD, Robin Norris, MD MS, MPH, Erin H. Breese, MD PhD, Christine L Phillips, MD, Karen Burns, MD, Benjamin Mizukawa, Lynn Lee, MD, Adam Lane, PhD, Robert B. Lorsbach, MD PhD, Thomas D. Ryan, MD PhD, Pankaj B. Desai, PhD, Alexander A. Vinks, PharmD, PhD, H. Leighton Grimes, PhD, John P Perentesis, Michael J. Absalon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3830.
https://doi.org/10.1182/blood-2019-121514
Published: 2019
Journal Articles

The Role of Macrophages in Bone Marrow Injury and Hematopoietic Reconstitution

Free
Wen Ju, Tiantian Sun, Wenyi Lu, Kailin Xu, MD, Jianlin Qiao, PhD, Lingyu Zeng, MD,PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3729.
https://doi.org/10.1182/blood-2019-127802
Published: 2019
Journal Articles

Exposure-Response Relationship of the SMART-Ig Anti-hC5 Antibody Crovalimab (SKY59): Results from the Umbrella Phase 1/2 Composer Trial in Healthy Volunteers and PNH Patients

Free
Alexandre Sostelly, M.Eng., PhD, Simon Buatois, Antoine Soubret, Erica Winter, PharmD, Barbara Klughammer, PhD, Joy C. Hsu, Gregor Jordan, Christoph Bucher, MD, Jean-Eric Charoin, Keisuke Gotanda, Kenji Shinomiya, Zsolt Nagy, MD PhD, Jens P. Panse, Sung-Soo Yoon, MD PhD, Régis Peffault de Latour, MD PhD, Junichi Nishimura, MD PhD, Alexander Röth, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3745.
https://doi.org/10.1182/blood-2019-124258
Published: 2019
Journal Articles

Phase 3 Exploratory Analysis of Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Received Consolidation with CPX-351 Versus Conventional Chemotherapy

Free
Jonathan E. Kolitz, MD, Daniel H. Ryan, MD, Laura F. Newell, MD, Stephen A. Strickland, MD, Donna E. Hogge, MD PhD, Scott R. Solomon, MD, Gary J. Schiller, MD, Robert J. Ryan, MS, Stefan Faderl, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3856.
https://doi.org/10.1182/blood-2019-124553
Published: 2019
Journal Articles

CPX-351 As First Intensive Therapy for Elderly Patients with AML

Free
Ellen K. Ritchie, MD, Sumaiya K. Miah, BA, Sangmin Lee, MD, Tania Curcio, Pinkal Desai, MDMPH, Jeffrey Ball, MD, Michael B. Samuel, MD, Gail J. Roboz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3858.
https://doi.org/10.1182/blood-2019-130263
Published: 2019
Journal Articles

Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis

Free
Daniel H. Ryan, MD, Laura F. Newell, MD, Ellen K. Ritchie, MD, Stephen A. Strickland, MD, Donna E. Hogge, MD PhD, Scott R. Solomon, MD, Richard M. Stone, MD, Gary J. Schiller, MD, Matthew J. Wieduwilt, MD PhD, Robert J. Ryan, MS, Stefan Faderl, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3842.
https://doi.org/10.1182/blood-2019-124516
Published: 2019
Journal Articles

Efficacy and Safety of PD-1 Inhibitor Plus GVD Chemotherapy in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMLBCL)

Free
Qian Mei, PhD, Wenying Zhang, MD, Yang Liu, MD, Qingming Yang, MD, John E.J. Rasko, MBBS, PhD, Weidong Han, PhD MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4072.
https://doi.org/10.1182/blood-2019-121768
Published: 2019
Journal Articles

Multi-Center Retrospective Evaluation of High-Dose Cytarabine Based Induction Versus CPX-351 Induction in Patients with Secondary AML

Free
Lydia Benitez, PharmD, Anthony J. Perissinotti, PharmD, Caitlin R. Rausch, PharmD, Jeff Klaus, PharmD, Stephen Michael Clark, PharmD, Michael Filtz, PharmD, Kelley L Ratermann, PharmD, Carissa F. Treptow, PharmD, Shawn Griffin, PharmD, Marissa Olson, PharmD, Mallory Crain, PharmD, Kristen Pettit, MD, Patrick W. Burke, MD, Dale L. Bixby, MD, Bernard Lawrence Marini, PharmD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2639.
https://doi.org/10.1182/blood-2019-122189
Published: 2019
Journal Articles

Liposomal Cytarabine and Daunorubicin (CPX-351) in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Patients with Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)

Free
Jorge M. Ramos Perez, Tapan M. Kadia, MD, Guillermo Montalban-Bravo, MD, Christopher B. Benton, MD, Stefan Faderl, Koji Sasaki, MD, Kiran Naqvi, MDMPH, Jorge E. Cortes, MD, Naval G. Daver, MD, Courtney D. DiNardo, MDMSc, Elias Jabbour, MD, Gautam M. Borthakur, MD, Hind Al Azzawi, Naveen Pemmaraju, MD, Marina Y Konopleva, MD PhD, Sherry A. Pierce, BSN, BA, Nitin Jain, MD, Maro Ohanian, DO, Guillermo Garcia-Manero, MD, Michael Andreeff, MD PhD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Yesid Alvarado, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2642.
https://doi.org/10.1182/blood-2019-129137
Published: 2019
Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial

Free
Hui-qiang Huang, Yunhong Huang, MD PhD, Gao Yan, Haiyan Yang, Qingyuan Zhang, Runxiang Yang, Min Zhou, PhD, Yufu Li, Yan Li, Lihong Liu, Hui Zhou, MD PhD, Hongmei Jing, Zhigang Peng, MD, Ding Yu, Rong yan Zhang, Bing Xu, Xiaohong Zhang, Junyuan Qi, Liping MA, MD, Shan Chen, Jianfei Xue
Journal: Blood
Blood (2019) 134 (Supplement_1): 2838.
https://doi.org/10.1182/blood-2019-126481
Published: 2019
Journal Articles

High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed and Refractory Classical Hodgkin Lymphoma

Free
Alison J. Moskowitz, MD, Gunjan L. Shah, MDMS, Heiko Schoder, MD, Helen Hancock, ANP, Theresa Davey, MMSc, PA-C, Christopher Joong, BS, Lauren Pomerantz, BS, Christine Jarjies, MS, Anita Kumar, MD, Oscar B Lahoud, MD, Connie Lee Batlevi, MD PhD, Paul A. Hamlin, MD, David J. Straus, MD, Ildefonso Rodriguez-Rivera, MD, Colette Owens, MD, Philip Caron, MD PhD, Donald Steven Colbourn, MD, Andrew M. Intlekofer, MD PhD, Audrey Hamilton, MD, Steven M. Horwitz, MD, Erel Joffe, MDMSc, M. Lia Palomba, MD, Ariela Noy, MD, Matthew J Matasar, MD, Santosha Vardhana, MD PhD, Gottfried R. von Keudell, MD PhD, Joachim Yahalom, MD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Craig H. Moskowitz
Journal: Blood
Blood (2019) 134 (Supplement_1): 2837.
https://doi.org/10.1182/blood-2019-127575
Published: 2019